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Available online 15 August 2014In the past three decades, endothelin and endothelin receptor antagonists have received great scientiﬁc and
clinical interest, leading to the publication of more than 27,000 scientiﬁc articles since its discovery. The
Thirteenth International Conference on Endothelin (ET-13)was held on September 8–11, 2013, at Tokyo Campus
of the University of Tsukuba in Japan. Close to 300 scientists from 25 countries from around the world came to
Tokyo to celebrate the anniversary of the discovery of the endothelin peptide discovered 25 years ago at the
University of Tsukuba. This article summarizes some of the highlights of the conference, the anniversary celebra-
tion ceremony, and particularly the participation of next generation of endothelin researchers in endothelin
science and the anniversary celebration. As a particular highlight, next generation endothelin researchers
wrote a haiku (a traditional form of Japanese poetry originating from consisting of no more than three short
verses and 27 on, or Japanese phonetic units) to describe the magic of endothelin science which they presented
to the conference audience at the anniversary ceremony. The text of each haiku – both in its original language
together with the English translation – is part of this article providing in an exemplary fashion how poetry can
be bridged with science. Finally, we give an outlook towards the next 25 years of endothelin research.
© 2014 Elsevier Inc. All rights reserved.E.T. is coming home: Anniversary conference at the
University of Tsukuba
In 1980, Robert Furchgott together with John Zawadzki published
his observation that endothelial cells release a relaxing factor, aarmacy, Kobe Pharmaceutical Unive
apan.
ional Conference on Endothelin, Savandiscovery that ultimately would bring him the 1996 Lasker Award
(Furchgott, 1996) and the 1998 Nobel Prize in Physiology or Medicine
(Mitka, 1998; Williams, 1998). At the same time Hollywood director
Steven Spielberg had started his work on “E.T., the Extraterrestrial”, a
science ﬁction movie about a friendly alien lost on planet Earth, whichrsity, and Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe
nah, Georgia, U.S.A., September 2–5, 2015.
78 N. Emoto et al. / Life Sciences 118 (2014) 77–86has been named one of the 100 best movies ever made since 1923
by Time magazine (Corliss, 2011). In 1982, when “E.T.” hit the
silver screen, de Mey and Vanhoutte's work on the discovery of
endothelium-dependent vasoconstriction was published (Barton,
2011; De Mey and Vanhoutte, 1982). Endothelial cell research to-
wards the identiﬁcation of the factor described by Furchgott virtually
exploded shortly thereafter, but instead resulted in preliminary
reports of the release of a peptidergic endothelial vasoconstrictor
substance (Hickey et al., 1985; O'Brien et al., 1987; Rubanyi, 2011),
the identity of which was ﬁnally unmasked within half a year of
research work by Yanagisawa, Masaki, Goto and colleagues were
at the University in Tsukuba, Japan, and gene and peptide sequences
were disclosed in a paper published in Nature in 1988 (Yanagisawa
et al., 1988b). Due to its endothelial cell origin, the peptidergic vaso-
constrictor was named endothelin — abbreviated as “ET”, like the
Hollywood movie. Ironically, in the movie the main character, a
little boy named Elliot, says to ET: “You could be happy here […] we
could grow up together”. As it turns out, exactly this is what
happened to many scientists who have embarked in endothelin
research since it was discovered at the University of Tsukuba a
quarter of a century ago and who in fact did grow up and spent
their life with endothelin.Fig. 1. 1: ET-13 Presidential Dinner Announcement board. 2 and 3: Professor Paul Vanhoutte
Conference on Endothelin, held on September 9, 2013 at the Hotel Chinzanso Toyko. PhotograThe Thirteenth International Conference on Endothelin (ET-13) was
held on September 8–11, 2013, at Tokyo Campus of the University of
Tsukuba (Emoto et al., 2014ab). On the occasion of the 25th anniversary
of the discovery, close to 300 scientists from 25 countries from around
the world came to Tokyo, where the conference was hosted by Chairs
Professors Noriaki Emoto and Takashi Miyauchi. Honorary Conference
Chairs were Professors Tomoh Masaki, Katsutoshi Goto, Paul M.
Vanhoutte and Masashi Yanagisawa. Two years earlier, at the Twelfth
International Conference on Endothelin (ET-12) in Cambridge, UK, the
inaugural, First Tomoh Masaki Award had been presented to
Professor Masashi Yanagisawa. He recently returned home to the
University of Tsukuba, where he, in the 1980s, summarized the discov-
ery of endothelin in his Ph.D. thesis as a graduate student of Professor
Tomoh Masaki (Barton et al., 2012a). Work and contributions of re-
searchers leading to the discovery of endothelin and its receptors have
been published in previous articles (Barton et al., 2012a; Masaki, 1989,
1998, 2004; Masaki and Sawamura, 2006). To the great joy of the
Conference Faculty, Professor Tomoh Masaki, who will be celebrating
his 80th birthday in October 2014, was able to attend the ET-13 festivi-
ties (Fig. 1), and also enjoyed a chamber music concert performed by
world-renowned musicians Dimitri and Vovka Ashkenazy prior to the
Presidential Dinner (Fig. 3).and Professor Tomoh Masaki at the Presidential Dinner of the Thirteenth International
phs courtesy of Angus Hubbard, London, United Kingdom.
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Masaki Award
At the Thirteenth International Conference on Endothelin, Professor
Katsutoshi Goto was honored as the recipient of the Second Tomoh
Masaki Award (Emoto et al., 2014b) (Fig. 2). Professor Goto, a pharma-
cologist by training, importantly contributed to the puriﬁcation of
endothelin, and also set up the in vitro assays using aortic ring prepara-
tions (Vane, 1990). In work led by Professor Masaki and Professor
Yanagisawa and with the support of the biochemist Professor Sadao
Kimura, Professor Goto's efforts also helped characterize the endothelinFig. 2. 1 through 3: Impressions from the Young Investigator Award Ceremony. 4 and 5: Pre
Conference Chairs. On behalf of the recipient Professor Goto who was unable to attend the co
accepts the award. All photographs courtesy of Suzete Sandin, Sherbrooke, Canada.peptide as a vasoactive substance in rats (Yanagisawa et al., 1988a). At
the ET-13 conference, Professor Yanagisawa accepted the award on
behalf of Professor Goto who was unable to attend the conference
(Fig. 2). During the award ceremony, Professor Yanagisawa presented
the audience with memories and historical anecdotes on working
with Professor Goto as a graduate student in Professor Masaki's labo-
ratory (Fig. 2). Professor Yanagisawa pointed out how crucial and in-
strumental Professor Goto's support had been in the process of the
discovery of endothelin, again emphasizing the importance of good
mentorship and clear scientiﬁc communication (Barton and Pollock,
2012; Emoto et al., 2014b).sentation of The Second Tomoh Masaki Award to Professor Katsutoshi Goto by the ET-13
nference and is shown on the slide in the background (5), Professor Masashi Yanagisawa
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During the preparation for ET-13 and after the ﬁrst conference ab-
stracts had been submitted, the Conference Chairs realized that ET-13
was going to be the ﬁrst endothelin conference to include presenters
who were born after the discovery of endothelin (the ﬁnal manuscript
was submitted to Nature on December 1, 1987, and published March
30, 1988 (Yanagisawa et al., 1988b)). As a period of 25 years reﬂects a
generation it became clear that these young scientists, aged 25 or less
in 2013, indeed are the next generation of endothelin researchers
(Fig. 4). The importance of promoting young scientists in the endothelin
ﬁeld (Figs. 2, 4, and 5) (and in biomedical research in general) has al-
ready been discussed in an article in Endothelin XII, the Proceedings of
the previous endothelin conference (Barton et al., 2012b), by Professors
Matthias Barton and David Pollock (Barton and Pollock, 2012).
Since it was discovered at the University of Tsukuba by graduate stu-
dentMasashi Yanagisawa,whoat the timewasworking under themen-
torship of Professor Tomoh Masaki, endothelin has always been linked
to Japan (Emoto et al., 2014b). Moreover, the ET-13 conference provid-
ed a chance to celebrate the discovery of endothelin at its birthplace, the
University of Tsukuba, a quarter of a century later.Fig. 3. 1:World-renownedmusicians, Pianist Vovka Ashkenazy and Clarinetist Dimitri Ashkena
the 25th anniversary of the discovery of endothelin. 2: Professor Masashi Yanagisawa discusse
mance. Photographs courtesy of Angus Hubbard, London, United Kingdom.With the aim to further improve the visibility of the new generation
(Figs. 2, 4, and 5), the ET-13 Conference Chairs, Professors Noriaki
Emoto and Takashi Miyauchi, not only invited younger researchers to
join the conference faculty, but also increased the number of Young In-
vestigator Awards and Travel Grants to an unprecedented level (Emoto
and Yanagisawa, 2014) (Figs. 3 and 5).
Young investigators have alsways been a key element of the interna-
tional Endothelin Conferences, and this was also the case at ET-13
(Fig. 5). To further highlight their essential role in endothelin research
(Barton and Pollock, 2012), Angus Hubbard (U.K.) presented to the
Conference Chairs the idea to introduce - as a ﬁrst for any Endothelin
Conference - a new series of online-only interviews having a young re-
searcher and an established investigator in the ﬁeld of endothelin re-
search discuss about endothelin and their career in science. This newly
launched series was named “The Endothelin Talks” (Appendix A).
Filmed and recorded on site at ET-13 in Tokyo, the ﬁrst set of Endothelin
Talks include discussions between Julia Straube (Germany) andMasashi
Yanagisawa (Japan), between Rebecca Moorhouse (U.K.) and Paul M.
Vanhoutte (Hong Kong), and between Meghana Pandit and Donald E.
Kohan (both U.S.A.). The Endothelin Talks are being published with
this article and are available online (Appendix A).zy, performing at the Presidential Dinner Concert on September 9, 2013, on the occasion of
s music with the artists after standing ovations for the musicians for a wonderful perfor-
Fig. 4. The next generation of endothelin researchers. 1: Julia Straube, Germany responding to the questions of the audience after her oral presentation. 2: Rhéure Alves Moreira Lopes,
Brazil, during the poster session. 3: Rebecca Moorhouse, (Edinburgh, U.K.). 4: Aiko Sonobe (Tsukuba, Japan) and Joseph Cacioppo (Urbana, IL, U.S.A.), with Professor Jennifer Pollock
(Augusta, GA, U.S.A., now Alabama, AL, U.S.A.). 5: Raphael Wurm (Vienna, Austria), during his oral presentation 6: Joseph Cacioppo with Dr. Anthony Davenport (Cambridge, U.K.) at
his poster. 7: Danielle Kamato (Melbourne, Australia), Rhéure Alves Moreira Lopes (Ribeirão Preto, Brazil, in the back) and Thomas Leurgans (Odense, Denmark, in light blue shirt), at
the posters. 8 and 9: Louisane Desbiens (Sherbrooke, Canada) with Professor Jo de Mey (Odense, Denmark). 10: Danielle Kamato at the posters. 11: Professors Matthias Barton (Zurich,
Switzerland) and Adviye Ergul (Augusta, GA, U.S.A.; ET-14 Conference Chair-elect), and Professor Masashi Yanagisawa (Tsukuba, Japan) at the celebration ceremony of the 25th anniver-
sary of the discovery of endothelin. All photographs courtesy of Suzete Sandin, Sherbrooke, Canada.
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As this was the 25th anniversary meeting, the Conference Chairs de-
cided to showcase their youngest colleagues and their creative abilities
unrelated to science at ET-13 during the ceremony of the anniversary
celebration.
As one of the highlights of the celebration ceremony, the Conference
Chairs launched a haiku (俳句) contest. A haiku is a traditional form of
Japanese poetry originating from consisting of no more than three
short verses and 27 on, or Japanese phonetic units. A haiku often poeti-
cally depicts a natural scenery and juxtaposes two images or ideas,
which might at ﬁrst sight sound opposite like the small and the
immense, the near and the far away. Haikus are deeply rooted in the
Japanese culture but are now acclaimed and used around the world.
The idea of organizing a haiku contest came out quite naturally, since
a haiku is characterized by its simplicity in the form and beautiful com-
plexity in the meaning – just like endothelin might be.
Nine investigators under 25 years of age had submitted a research
abstract which they presented at the conference and who were invited
to participate in the contest. They all accepted and embraced the projectFig. 5. ET-13 Best Presentation Awards, co-sponsored by Elsevier Publishers, for the best oral p
Cardiology Heidelberg University, Germany, during his presentation. 2: Awardee Dr. David Du
his poster. 3 and 4: The ET-13 Conference Chairs, Professors Noriaki Emoto and Takashi Miyau
Suzete Sandin, Sherbrooke, Canada.with great enthusiasm. In very personal ways, combining science with
poetry, they described the history of endothelin research, the hopes
the research in the ﬁeld has created and –most of all – thework that re-
mains to be done to further uncover the complexity of endothelin's
biology. The vascular origin of endothelin was a theme in several of
the haikus presented, and endothelin's multiple, non-vascular func-
tionswere presented aswell. Most importantly, the young investigators
in their haiku put the light on the global scale of today's research. At
the same time, the human aspects reﬂected in some of these presenta-
tions conﬁrmed once more that research on endothelin (often referred
to as the “endothelin peptide family”) indeed resembles in many
aspects a family the members of which enjoy coming together again
every two years in a city from around the world to share discoveries
and friendship.
At the Conference Dinner on September 10th, 2013, the next
generation of endothelin researchers presented their scientiﬁc
poetry to some members of the “ﬁrst generation” of endothelin sci-
entists with much humor and self-conﬁdence (Figs. 6 and 7). As all
contributions were outstanding, every contestant was named a
winner.resentation and best poster presentation. 1: Awardee Dr. Johannes Backs, Department of
rgan, Department of Anesthesiology, Baylor College of Medicine, Houston, Texas, USA, at
chi present the presentation awards to the award recipients. All photographs courtesy of
83N. Emoto et al. / Life Sciences 118 (2014) 77–86The haikus of the winners (with their year of birth in parentheses)
follow below, both in the original language, and their English translation.
They might well be considered “birthday-gifts for its 25 birthday” to
endothelin science:
Joseph Cacioppo (1989) The Department of Comparative Biosci-







sFrom cells derived, your
ame arises; many years
ince then have ﬂown by."Once cleansing, kidneys
Falter, and spreading throughout
Now track toxins too."In early life you
Keep us warm, and hunger you
Hold at bay as well.Vessels contract, blood
Flow quickens. Function explored,
New purposes course.Not unlike cousins
From serpents’ fangs, your subtle
Rise can bring demise.And lest all mice are
Spotted, all foals deaf, know your
Actions are heard wide.earts draw inward, face
creased pressure, solid their
alls grow forever.Yet also needed
As life begins for eggs to
Break surface within.As we glance back to
Glimpse the past, the future shines
Bright as scenes unfold.ease compliance as
cars now thicken the green blue
hreads beneath the skin.”For new strands to twist
While hearts do loop, connecting
Each to the other.”Much to learn have we,
And much to teach do you, on
Life, all parts, so dear.”t
Louisane Desbiens (1989) Department of Pharmacology, Université
de Sherbrooke, Sherbrooke, Canada:French original“Un accord subtil,
La chymase dans l'hiatus
Des endothélines”“A subtle chord
Chymase in the cacophony
Of endothelins”Thomas Leurgans (1989) Department of Cardiovascular and
Renal Research, the University of Southern Denmark, Odense,
Denmark:Dutch original“Familie van drie,
Tonen veel gelijkenis.
Toch zo verschillend”“Family of three,
Look a lot like each other.
Yet so different”Rebecca Moorhouse (1988) Queen's Medical Research Institute,
University of Edinburgh, Edinburgh, UK:“Sowing of a seed
branching in new directions
learning, year on year”Raphael Wurm (1989) Medical University of Vienna, Austria:German original“Die Gefässe zu verstehen
Bedeutet
Allen Fluss zu begreifen”“Understanding the vasculature
Means
Comprehending the ﬂow of everything”Julia Straube (1990) Department of Pathology, University Hospital,
Cologne, Germany:German original“Gefässzauberer,
25 Jahre, weiter suchend
Austausch von Nöten”“Vascular wizard —
25 years, still lifting the fog
In need of a blog.”Rhéure Alves Moreira Lopes (1988) University of São Paulo, Medical
School of Ribeirão Preto, Brazil:Portuguese original“Isso é minha sorte!
Conhecer o Japão.
Falar sobre endotelina”“That's my good luck!
To meet Japan.
To talk about endothelin.”Danielle Kamato (1990) Health Innovations Research Institute,
RMIT University, Melbourne, Australia:“ET-1 opens
Apamin Ion Channels
No its IP3”Aiko Sonobe (1990) University of Tsukuba, Tsukuba, Japan:Japanese original“Twenty-one
Spreading around the globe
Peptide”One of the Conference Chairs-elect of the next endothelin meeting
and Master of Ceremony of the Haiku contest (Figs. 6 and 7) surprised
the Conference Chairs with a haiku which gives us a glimpse of the
ET-14 conference to be held in 2015:
Adviye Ergul, Georgia Regents University, Augusta, Georgia, United
States of America:“Pink azaleas bloom
Live oaks with Spanish moss shine
Savannah we meet”
Fig. 7. Haiku contest winners from all parts of the world: Danielle Kamato (Melbourne, Australia), Rebecca Moorhouse (Edinburgh, U.K.), Joseph Cacioppo (Urbana, IL, U.S.A.), Thomas
Leurgans (Odense, Denmark), Louisane Desbiens (Urbana, Canada), Raphael Wurm (Vienna, Austria), Rhéure Alves Moreira Lopes (Ribeirão Preto, Brazil), and Julia Straube (Köln,
Germany), shown with Professors Adviye Ergul (in an original japanese kimono and footwear), Matthias Barton, and Masashi Yangisawa. Photograph courtesy of Suzete Sandin, Sher-
brooke, Canada.
Fig. 6. Top panel: All generations of endothelin researchers have come together for the ceremonyof the 25th anniversary of the discovery of endothelin (from left to right): Professor Pedro
d'Orléans-Juste (Sherbrooke, Canada), ProfessorDavid Pollock (Augusta, GA, U.S.A. nowAlabama, AL, U.S.A.; ET-14 Conference Chair-elect), Dr. Ariela Benigni (Bergamo, Italy), Dr. Anthony
Davenport (Cambridge, U.K.), Professor Paul Vanhoutte (HongKong, China), Professor TakashiMiyauchi (Tsukuba, Japan), Professor Adviye Ergul, (Augusta, GA, U.S.A., wearing an original
Japanese kimono and footwear; ET-14 Conference Chair-elect); Next generation endothelin researchers Danielle Kamato (Melbourne, Australia), Rebecca Moorhouse, (Edinburgh, U.K.),
Joseph Cacioppo (Urbana, IL, U.S.A.), Thomas Leurgans (Odense, Denmark), Louisane Desbiens (Sherbrooke, Canada), Raphael Wurm (Vienna, Austria), Rhéure Alves Moreira Lopes
(Ribeirão Preto, Brazil), Julia Straube (Köln, Germany), Professor Matthias Barton (Zürich, Switzerland), Professor Masashi Yanagisawa (Tsukuba, Japan), Professor Noriaki Emoto
(Kobe, Japan), Professor Jun Yamashita (Kyoto, Japan), Professor Donald Kohan (Salt Lake City, UT, U.S.A.), and Professor David Webb (Edinburgh, U.K.). Professors Tomoh Masaki
(Tokyo, Japan), and Katsutoshi Goto, (Tsukuba, Japan) were unable to attend the ceremony. Bottom left panel: The Haiku contestants after their presentations in front of the typical,
Japanese-style cartoon “Endothelin's 25th anniversary celebration” poster, with the “Masters of Ceremony”, Professors Adviye Ergul and Matthias Barton, with Professor Yanagisawa.
Bottom right panel: The ET-13 Conference Chairs Professors Takashi Miyauchi and Noriaki Emoto, celebrating and shown with the “Endothelin Birthday Cake”. All photographs courtesy
of Suzete Sandin, Sherbrooke, Canada.
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Conference attendees presented work and lectures on clinical
studies in nephrology, cardiology, internal medicine (Campia et al.,
2014), oncology, dermatology, ophthalmology, as well as basic
research, including physiology, biochemistry, pharmacology (Shimojo
et al., 2014), and molecular biology. Potential applications of new
endothelin receptor antagonists in parasitic diseases were discussed
(Dai et al., 2012; Freeman et al., 2014), and clinical presentations
addressed treatment of pulmonary arterial hypertension (Adachi et al.,
2014) as well as hopes (Adlbrecht et al., 2014) and disappointments of
clinical trials (Kohan et al., 2012; Reichetzeder et al., 2014).Endothelin research — The next 25 years
After a quarter of a century, endothelin has reached all continents
(Fig. 8), projects studying endothelin produced more than 27,000 re-
search articles (Barton and Pollock, 2012), and pharmaceutical research
resulted in the development of new, orally active drugs (Kohan et al.,
2012), three of which are now available to physicians to treat patients
with life-threatening diseases (Miyagawa and Emoto, 2014; Rubin,
2012; Tanabe et al., 2014). What began in 1988 with the isolation of
the endothelin peptide from endothelial cells, followed by the discovery
of its receptors shortly thereafter (reviewed in Barton and Yanagisawa,
2008), has resulted in a tremendous advancement of knowledge, both
in basic science as well as in clinical medicine where new treatments
for human disease are now available (Miyagawa and Emoto, 2014;
Rubin, 2012; Tanabe et al., 2014). For more than ten years endothelin
antagonists have been part of the therapeutic armamentarium of physi-
cians treating pulmonary arterial hypertension (Miyagawa and Emoto,
2014; Rubin, 2012; Tanabe et al., 2014), and the development of new
therapeutic targets continues (Kohan et al., 2012). We expect that
within the next decades well-designed clinical studies using endothelin
receptor antagonists at the right dose and in the right patients for theFig. 8.Graphic summary of countries accessing lectures and presentations of the ET conferences
the endothelin presentation videos have been watched more than 60,000 times in over 100 co
Source: vimeo.com.right therapeutic indication might reveal a new way by which interfer-
ing with endothelin action may improve health and prolong lives
(Barton et al., 2006; Kohan and Barton, in press; Kohan et al., 2012;
Said et al., 2011; Said and Theodorescu, 2012; Schneider and Mann,
2014).
In 2011, the International Advisory Board of the International
Conferences on Endothelin launched its website (Endothelins.com,
2011) with the goal to inform and educate patients, scientists, students,
and laymen about endothelin as well as past and future endothelin
conferences. The ET-12 Conference Chairs started the tradition to
make video recordings of presentations delivered at the endothelin
conferences and to provide access to these presentations, thereby creat-
ing a permanent record of the endothelin conferences (Barton et al.,
2012b). This tradition that has been continued at ET-13, and all presen-
tations are now available online (Media data base, 2012). Over the past
two years, the presentation videos on the endothelin website has been
accessed more than 60,000 times from over 100 countries around the
world (Fig. 8), averaging currently about 100 visits per day, a number
we expect to increase even further. We are much looking forward to
the next conference to be held from September 2–5, 2014 in Savannah,
Georgia, U.S.A. (ET-14, 2014). We wish the ET-14 Conference Chairs,
Professors Adviye Ergul, David Pollock, and Anil Gulati, much success
with their meeting and to again welcome and accompany the next
generation of endothelin researchers to continue its scientiﬁc journey.
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